Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Archives of General Psychiatry – September 07, 2010
Source: OpenAlex
Summary
A single dose of psilocybin, administered with psychological support, significantly reduced anxiety and improved mood in cancer patients. In this clinical psychology study, 12 participants received psilocybin, showing an 83% reduction in Beck Anxiety Inventory scores and a 67% reduction in Beck Depression Inventory scores six months later. Profile of Mood States also improved by 30-40%. This Psychiatry research indicates psilocybin, derived from chemical synthesis and alkaloids, holds promise for mental health. No serious adverse effect was reported, advancing Psychedelics and Drug Studies beyond Cannabis and Cannabinoid Research.
Abstract
clinicaltrials.gov Identifier: NCT00302744.